What are the indications for plasma exchanges in autoimmune diseases?: The registry of the Société Française d'Hémaphérèse

Transfusion and Apheresis Science

Volumn 36, Issue 2, 2007, Pages 173-177

  Petitpas, D ^a,b   Ould Zein, S ^a,b   Korach, J M ^a,b  

^a General Hospital   (France)

^b The French Registry Cooperative Group   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

ARTICLE; AUTOIMMUNE DISEASE; DEVELOPING COUNTRY; DRUG MEGADOSE; FRANCE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MORBIDITY; MYASTHENIA GRAVIS; PLASMAPHERESIS; THROMBOCYTOPENIC PURPURA;

AUTOIMMUNE DISEASES; FRANCE; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; PLASMA EXCHANGE; REGISTRIES;

EID: 34248171836     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2007.01.007     Document Type: Article

References (15)

1. Lockwood C.M., Rees A.J., Pearson T.A., Evans D.J., Peters D.K., and Wilson C.B. Immunosuppression and plasma exchange in the treatment of Goopasture's syndrome. Lancet 1 7962 (1976) 723-726
2. Gajdos P., Chevret S., and Toyka K. Plasma exchange for myasthenia gravis. Cochrane Database Syst Rev 4 (2002) CD002275
3. Gajdos P., Chevret S., Clair B., Tranchant C., and Chastang C. Plasma exchange and intravenous immunoglobulin in autoimmune myasthenia gravis. Ann NY Acad Sci 13 841 (1998) 720-726
4. Weinshenker B.G., O'Brien P.C., Petterson T.M., et al. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol 46 6 (1999) 878-886
5. Weinshenker B.G., Wingerchuk D.M., Vukusic S., Linbo L., and Pittock S.J. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol 59 3 (2006) 566-569
6. Korach J.-M., Ould-Zein S., Fadel F., Petitpas D., Chillet P., and Berger Ph. Echanges plasmatiques (EP) et microangiopathies thrombotiques (MAT) en France 1991-2003. Réanimation 14 Suppl. 1 (2005) 114-115
7. Coppo P., Bengoufa D., Veyradier A., Wolf M., Bussel A., Millot G.A., et al. Reseau d'Etude des Microangiopathies Thrombotiques de l'Adulte. Severe ADAMTS13 deficiency in adult idiopathic thrombotic microangiopathies defines a subset of patients characterized by various autoimmune manifestations, lower platelet count, and mild renal involvement. Medicine (Baltimore) 83 4 (2004) 233-244
8. Coppo P, Veyradier A, Fremeaux-Bacchi V. Microangiopathies thrombotiques de l'adulte de plus de 15 ans: établissement d'un registre et étude prospective de l'activité de la protéase spécifique du facteur von-Willebrand et du facteur H. PHRC promoteur AP-HP.
9. Otsubo S., Tanabe K., Shinmura H., Ishikawa N., Tokumoto T., Hattori M., et al. Effect of post-transplant double filtration plasmapheresis on recurrent focal and segmental glomerulosclerosis in renal transplant recipients. Ther Apher Dial 8 4 (2004) 299-304
10. Deegens J.K., Andresdottir M.B., Croockewit S., and Wetzels J.F. Plasma exchange improves graft survival in patients with recurrent focal glomerulosclerosis after renal transplant. Transplant Int 17 3 (2004) 151-157
11. Salama A.D., Levy J.B., Lightstone L., and Pusey C.D. Goodpasture's disease. Lancet 358 9285 (2001) 917-920 15
12. Josse A.G., Kamar N., Bauvin E., Korach J.M., Canses-Lauwers V., et al. One-year survival and renal function outcome in patients treated by plasmapheresis for Goodpasture syndrome: a 73 case report study. Neph Dial Transplant 18 Suppl. 4 (2003) 70
13. Pagnoux C., Korach J.M., and Guillevin L. Indications of plasma exchanges in systemic lupus erythematosus in 2005. Lupus 14 (2005) 871-877
14. Guillevin L. Echanges plasmatiques dans les maladies systémiques: leur place actuelle. Réanimation 11 (2002) 359-365
15. Stegmayr B., Korach J.M., Norda R., Rock G., and Fadel F. Is there a need for a national or a global apheresis registry. Transfus Apher Sci 29 2 (2003) 179-185